• Vanessa Neef, Suma Choorapoikayil, Lotta Hof, Patrick Meybohm, and Kai Zacharowski.
• Goethe University Frankfurt, University Hospital, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Germany.
• Curr Opin Anaesthesiol. 2024 Jun 1; 37 (3): 234238234-238.

Purpose Of ReviewPostpartum anemia (PPA) is common in women after childbirth and affects about 50-80% of all women worldwide. Iron deficiency (ID) is the main cause for anemia and constitutes a potentially preventable condition with great impact on the mother's physical and mental condition after delivery. In most cases, PPA is associated with antenatal ID and peripartum blood losses. Numerous published studies confirmed the positive effect of PPA diagnosis and treatment.Recent FindingsIron deficiency as well as iron deficiency anemia (IDA) are common in the postpartum period and represent significant health problems in women of reproductive age.SummaryImportant movements towards early detection and therapy of postpartum anemia have been observed. However, postpartum anemia management is not implemented on a large scale as many healthcare professionals are not aware of the most recent findings in the field. Diagnosis and therapy of PPA, particularly iron supplementation in ID and IDA, has proven to be highly effective with a tremendous effect on women's wellbeing and outcome.Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

32 keywords...

hide…